The mammalian gut secretes a family of multifunctional peptides that affect appetite, intestinal secretions, and motility whereas others regulate the microbiota. We have found that peptide YY (PYY 1-36 ), but not endocrine PYY 3-36 , acts as an antimicrobial peptide (AMP) expressed by gut epithelial paneth cells (PC). PC-PYY is packaged into secretory granules and is secreted into and retained by surface mucus, which optimizes PC-PYY activity. Although PC-PYY shows some antibacterial activity, it displays selective antifungal activity against virulent Candida albicans hyphae—but not the yeast form. PC-PYY is a cationic molecule that interacts with the anionic surfaces of fungal hyphae to cause membrane disruption and transcriptional reprogramming that selects for the yeast phenotype. Hence, PC-PYY is an antifungal AMP that contributes to the maintenance of gut fungal commensalism.
Perturbed interactions between the intestinal microbes and host correlate with emergence of fungal virulence. Here we report a previously unknown role for peptide YY (PYY), a described endocrine molecule, as an antimicrobial peptide (AMP) expressed by gut immune epithelial Paneth Cells (PC). PC-PYY differs from other AMPs, including lysozyme, because of limited antibacterial activity, packaging in discrete secretory granules, and selective antifungal activity to virulent hyphae, but not yeast forms of Candida albicans. The latter action is through binding of cationic PC-PYY to the anionic hyphal surface, resulting in membrane disruption and killing. PC-PYY is compartmentalized to surface mucus, which optimizes activity and prevents conversion to endocrine PYY by dipeptidyl peptidase-IV (DPP-IV). We conclude PC-PYY is a unique AMP with selective antifungal activity that maintains gut fungal commensalism. Compromised PC-PYY action from PC dysfunction and/or mucus depletion in ileal Crohns disease may initiate or contribute to disease via fungal pathogenesis.
We have developed an innate immune model of colitis that occurs in the absence of adaptive immunity, is early-onset, 100% penetrant, chronic, and dependent on microbes. villin-TNFAIP3 transgenic mice, crossed to RAG1-/- mice (aka TRAG mice) develop innate immune-mediated colitis that is not observed in villin-TNFAIP3 or RAG1-/- littermates. Antibiotic treatment prevents colitis in TRAG mice. Thus, we sought to investigate the microbes that drive chronic innate immune colitis in the absence of adaptive immunity. To examine the spatial organization of bacteria, mucus and intestinal epithelium, bacteria and mucus were localized in Methyl-Carnoys-fixed sections of WT, villin-TNFAIP3, RAG1-/- and TRAG colons and mucus layers were collected by laser capture microdissection (LCM) for evaluation of bacterial populations. To test antibiotic effectiveness in colitis prevention, TRAG mice were treated with single antibiotic solutions of ampicillin, neomycin, metronidazole, or vancomycin, or with all antibiotics combined in a cocktail, and colitis was scored along the proximal-distal axis of the colon. Microbial populations along the proximal-distal axis of the gut were compared between RAG1-/- and TRAG mice by 16S sequencing. Microbial invasion of the mucus layer was abundant in villin-TNFAIP3 and in TRAG mice, but not WT or RAG1-/- mice. LCM indicated that a subset of microbes, of the classes Gammaproteobacteria and Actinobacteria, were over-represented in the mucus layer of TRAG mice. These included increased abundance of genera Serratia, Acinetobacter, Pseudomonas and Corynebacterium and decreased Bifidobacterium. Differences in antibiotic effectiveness were observed along the proximal-distal axis of the colon, with neomycin being most effective in prevention of inflammation in the cecum, while ampicillin was most effective in the distal colon. The proximal-distal communities of microbes in RAG1-/- mice were distinct and tightly grouped within the cecum, proximal colon, and distal colon, whereas this structure was lost in TRAG mice. In the RAG1-/- gut, the relative abundance along the proximal-distal axis decreased for Firmicutes (mainly Lachnospiraceae and Ruminococcacaea) and Proteobacteria (mainly Helicobacteriaceae and Desulfovibrionbacteriaceae) but increased for Actinobacteria (mainly Bifidobacteriaceae) and Bacteroidetes (mainly Bacteroidales). Unlike RAG1-/- mice, in TRAG mice the abundance of Bacteroidetes decreased along the proximal-distal gut axis. TRAG mice had higher abundance of Bifidobacterium animalis, Bacteroidetes acidifaciens and Lactobacilli and lower abundance of Lachnospiraceae, along the proximal-distal axis of the gut, compared to RAG1-/-mice. The cross-sectional and proximal-distal biogeography of microbes in RAG1-/- mice is disrupted in TRAG mice, which may contribute to the innate colitis observed in this model.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.